erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Nicola FG et al. | Characterization of erythromycin-resistant isolates of Staphylococcus aureus recovered in the United States from 1958 through 1969. | 1998 | Antimicrob. Agents Chemother. | pmid:9797248 |
| Johnson RC et al. | In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. | 1987 | Antimicrob. Agents Chemother. | pmid:3566246 |
| Schneider SC et al. | Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland. | 2015 | Antimicrob. Agents Chemother. | pmid:26195516 |
| Clewell DB and Franke AE | Characterization of a plasmid determining resistance to erythromycin, lincomycin, and vernamycin Balpha in a strain Streptococcus pyogenes. | 1974 | Antimicrob. Agents Chemother. | pmid:4618462 |
| RÃos AM et al. | Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection. | 2004 | Antimicrob. Agents Chemother. | pmid:15273098 |
| Kresken M et al. | High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin. | 2004 | Antimicrob. Agents Chemother. | pmid:15273149 |
| Katz KC et al. | Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001. | 2003 | Antimicrob. Agents Chemother. | pmid:12821502 |
| Jansen WT et al. | In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe. | 2007 | Antimicrob. Agents Chemother. | pmid:17606689 |
| Labro MT et al. | Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro. | 1986 | Antimicrob. Agents Chemother. | pmid:3019233 |
| Lee H et al. | Isolation of antibiotic hypersusceptibility mutants of Acinetobacter spp. by selection for DNA release. | 2003 | Antimicrob. Agents Chemother. | pmid:12654657 |
| Conejo Mdel C et al. | Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest. | 2003 | Antimicrob. Agents Chemother. | pmid:12654678 |
| Donowitz GR and Earnhardt KI | Azithromycin inhibition of intracellular Legionella micdadei. | 1993 | Antimicrob. Agents Chemother. | pmid:8285604 |
| Lindstrom TD et al. | Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human livers. | 1993 | Antimicrob. Agents Chemother. | pmid:8452357 |
| Mingoia M et al. | Heterogeneity of Tn5253-like composite elements in clinical Streptococcus pneumoniae isolates. | 2011 | Antimicrob. Agents Chemother. | pmid:21263055 |
| Grivea IN et al. | Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. | 2006 | Antimicrob. Agents Chemother. | pmid:16377695 |
| Vince R et al. | Binding of N-substituted erythromycyclamines to ribosomes. | 1976 | Antimicrob. Agents Chemother. | pmid:769668 |
| Hunaiti AA and Kolattukudy PE | Source of methylmalonyl-coenzyme A for erythromycin synthesis: methylmalonyl-coenzyme A mutase from Streptomyces erythreus. | 1984 | Antimicrob. Agents Chemother. | pmid:6143534 |
| Nielsen EI et al. | Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization. | 2011 | Antimicrob. Agents Chemother. | pmid:21807983 |
| Del Grosso M et al. | Tn2009, a Tn916-like element containing mef(E) in Streptococcus pneumoniae. | 2004 | Antimicrob. Agents Chemother. | pmid:15155196 |
| Song JH et al. | High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). | 2004 | Antimicrob. Agents Chemother. | pmid:15155207 |
| Nagata T et al. | Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model. | 2004 | Antimicrob. Agents Chemother. | pmid:15155229 |
| Novotny GW et al. | Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA. | 2004 | Antimicrob. Agents Chemother. | pmid:15388419 |
| Villedieu A et al. | Genetic basis of erythromycin resistance in oral bacteria. | 2004 | Antimicrob. Agents Chemother. | pmid:15155239 |
| Chang HR and Pechère JC | In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. | 1988 | Antimicrob. Agents Chemother. | pmid:2837140 |
| Wolter N et al. | Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation. | 2008 | Antimicrob. Agents Chemother. | pmid:18056269 |
| Pajukanta R et al. | In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. | 1992 | Antimicrob. Agents Chemother. | pmid:1329617 |
| Bonnet M and Van der Auwera P | In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence. | 1992 | Antimicrob. Agents Chemother. | pmid:1329619 |
| McCormack WM et al. | Hepatotoxicity of erythromycin estolate during pregnancy. | 1977 | Antimicrob. Agents Chemother. | pmid:21610 |
| Giovanetti E et al. | A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes. | 2002 | Antimicrob. Agents Chemother. | pmid:12435672 |
| Cynamon MH and Klemens SP | Activity of azithromycin against Mycobacterium avium infection in beige mice. | 1992 | Antimicrob. Agents Chemother. | pmid:1329622 |
| Reeves AR et al. | Analysis of an 8.1-kb DNA fragment contiguous with the erythromycin gene cluster of Saccharopolyspora erythraea in the eryCI-flanking region. | 2002 | Antimicrob. Agents Chemother. | pmid:12435693 |
| Dicuonzo G et al. | Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. | 2002 | Antimicrob. Agents Chemother. | pmid:12435707 |
| Bialer MG et al. | Erythromycin bioactivity is stable in ophthalmic ointment used for prophylaxis of neonatal gonococcal conjunctivitis. | 1987 | Antimicrob. Agents Chemother. | pmid:3619431 |
| Finland M et al. | Synergistic action of ampicillin and erythromycin against Nocardia asteroides: effect of time of incubation. | 1974 | Antimicrob. Agents Chemother. | pmid:4599860 |
| Akshay S et al. | Phylogenetic sequence variations in bacterial rRNA affect species-specific susceptibility to drugs targeting protein synthesis. | 2011 | Antimicrob. Agents Chemother. | pmid:21730122 |
| Tateda K et al. | Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. | 1996 | Antimicrob. Agents Chemother. | pmid:8891128 |
| Hunt Gerardo S et al. | Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. | 1996 | Antimicrob. Agents Chemother. | pmid:8891154 |
| Pannu J et al. | In vitro antibacterial activity of NB-003 against Propionibacterium acnes. | 2011 | Antimicrob. Agents Chemother. | pmid:21746943 |
| Descours G et al. | Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila. | 2017 | Antimicrob. Agents Chemother. | pmid:28069647 |
| Fernandes PB et al. | In vitro and in vivo activities of clarithromycin against Mycobacterium avium. | 1989 | Antimicrob. Agents Chemother. | pmid:2530933 |
| Wierzbowski AK et al. | Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides. | 2005 | Antimicrob. Agents Chemother. | pmid:16251306 |
| Xie Z et al. | Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates. | 2005 | Antimicrob. Agents Chemother. | pmid:16251329 |
| Zhou Z et al. | Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China. | 2015 | Antimicrob. Agents Chemother. | pmid:25451048 |
| Nash DR et al. | Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae. | 1991 | Antimicrob. Agents Chemother. | pmid:1901696 |
| Betriu C et al. | In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance. | 2004 | Antimicrob. Agents Chemother. | pmid:14693558 |
| Hunfeld KP et al. | Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi. | 2004 | Antimicrob. Agents Chemother. | pmid:14693564 |
| Golparian D et al. | In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea? | 2012 | Antimicrob. Agents Chemother. | pmid:22354296 |
| Rouse MS et al. | Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. | 1997 | Antimicrob. Agents Chemother. | pmid:9257739 |
| Green M et al. | Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania. | 2004 | Antimicrob. Agents Chemother. | pmid:14742197 |
| Fuursted K | Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension. | 1997 | Antimicrob. Agents Chemother. | pmid:9257743 |
| Jorgensen JH et al. | Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae. | 2004 | Antimicrob. Agents Chemother. | pmid:14742216 |
| Kenny GE and Cartwright FD | Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin. | 1991 | Antimicrob. Agents Chemother. | pmid:1903913 |
| Koelbl JA and Catlin BW | Vancomycin hypersusceptibility in Neisseria gonorrhoeae isolated from patients involves diverse mutations. | 1986 | Antimicrob. Agents Chemother. | pmid:3085585 |
| Simor AE et al. | Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. | 2007 | Antimicrob. Agents Chemother. | pmid:17724154 |
| Pankuch GA et al. | Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents. | 1998 | Antimicrob. Agents Chemother. | pmid:9517943 |
| Nagano N et al. | Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility. | 2008 | Antimicrob. Agents Chemother. | pmid:18809936 |
| Dörries K et al. | Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus. | 2014 | Antimicrob. Agents Chemother. | pmid:25224006 |
| Gentry DR et al. | Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus. | 2008 | Antimicrob. Agents Chemother. | pmid:18838584 |
| Gaudreau C et al. | Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni. | 2008 | Antimicrob. Agents Chemother. | pmid:18838597 |
| Pérez-Trallero E et al. | Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007). | 2010 | Antimicrob. Agents Chemother. | pmid:20439616 |
| Hardy DJ et al. | In vitro activity and in vivo efficacy of a new series of 9-deoxo-12-deoxy-9,12-epoxyerythromycin A derivatives. | 1991 | Antimicrob. Agents Chemother. | pmid:1854173 |
| Goldstein EJ et al. | Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections. | 2000 | Antimicrob. Agents Chemother. | pmid:10952607 |
| Bebear CM et al. | In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. | 2000 | Antimicrob. Agents Chemother. | pmid:10952617 |
| Hsueh PR et al. | High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. | 2001 | Antimicrob. Agents Chemother. | pmid:11600380 |
| Kouvela EC et al. | Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity. | 2009 | Antimicrob. Agents Chemother. | pmid:19164155 |
| Hao H et al. | Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni. | 2013 | Antimicrob. Agents Chemother. | pmid:23274667 |
| Goldfarb J et al. | Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo. | 1988 | Antimicrob. Agents Chemother. | pmid:3149884 |
| Hernould M et al. | Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance. | 2008 | Antimicrob. Agents Chemother. | pmid:18268083 |
| Ralph ED and Amatnieks YE | Potentially synergistic antimicrobial combinations with metronidazole against Bacteroides fragilis. | 1980 | Antimicrob. Agents Chemother. | pmid:6448574 |
| Lawrence L et al. | In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens. | 2008 | Antimicrob. Agents Chemother. | pmid:18316525 |
| Montilla A et al. | Genetic environment of the lnu(B) gene in a Streptococcus agalactiae clinical isolate. | 2014 | Antimicrob. Agents Chemother. | pmid:24957835 |
| Fuchs PC et al. | Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards. | 2002 | Antimicrob. Agents Chemother. | pmid:11796348 |
| Doern GV et al. | National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. | 1988 | Antimicrob. Agents Chemother. | pmid:3259121 |
| Croteau D et al. | Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography. | 1988 | Antimicrob. Agents Chemother. | pmid:3259856 |
| Swenson JM et al. | Susceptibility of Clostridium botulinum to thirteen antimicrobial agents. | 1980 | Antimicrob. Agents Chemother. | pmid:6998374 |
| Waites KB et al. | Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas. | 2008 | Antimicrob. Agents Chemother. | pmid:18663020 |
| Wu JJ et al. | High incidence of erythromycin-resistant streptococci in Taiwan. | 1997 | Antimicrob. Agents Chemother. | pmid:9087502 |
| Allen VG et al. | Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. | 2011 | Antimicrob. Agents Chemother. | pmid:21098249 |
| Wang H et al. | High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III. | 2013 | Antimicrob. Agents Chemother. | pmid:23295933 |
| Urich SK and Petersen JM | In vitro susceptibility of isolates of Francisella tularensis types A and B from North America. | 2008 | Antimicrob. Agents Chemother. | pmid:18411318 |
| Laohavaleeson S et al. | Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains. | 2008 | Antimicrob. Agents Chemother. | pmid:18411322 |
| Hsieh YC et al. | Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan. | 2008 | Antimicrob. Agents Chemother. | pmid:18413298 |
| Bacheson MA et al. | Antimicrobial susceptibility of intracellular Legionella pneumophila. | 1981 | Antimicrob. Agents Chemother. | pmid:7325633 |
| Barlam T and Neu HC | In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria. | 1984 | Antimicrob. Agents Chemother. | pmid:6732223 |
| Liu Y et al. | Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals. | 2009 | Antimicrob. Agents Chemother. | pmid:19029328 |
| Siibak T et al. | Erythromycin- and chloramphenicol-induced ribosomal assembly defects are secondary effects of protein synthesis inhibition. | 2009 | Antimicrob. Agents Chemother. | pmid:19029332 |
| Chan YY et al. | Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei. | 2007 | Antimicrob. Agents Chemother. | pmid:17145801 |
| Michel J et al. | Effects of subminimal inhibitory concentrations of Erythromycin, Clindamycin, and Pristinamycin on the penicillinase production of Staphlyococcus aureus. | 1980 | Antimicrob. Agents Chemother. | pmid:6965441 |
| Segreti J et al. | In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis. | 1987 | Antimicrob. Agents Chemother. | pmid:2952061 |
| Benson CA et al. | In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. | 1987 | Antimicrob. Agents Chemother. | pmid:2952063 |
| Gygax SE et al. | Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. | 2006 | Antimicrob. Agents Chemother. | pmid:16641466 |
| Srinivasan VB et al. | Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii. | 2009 | Antimicrob. Agents Chemother. | pmid:19770280 |
| Casal J | Antimicrobial susceptibility of Streptococcus pneumoniae: serotype distribution of penicillin-resistant strains in Spain. | 1982 | Antimicrob. Agents Chemother. | pmid:6927283 |
| Dowling JN et al. | Bactericidal activity of antibiotics against Legionella micdadei (Pittsburgh pneumonia agent). | 1982 | Antimicrob. Agents Chemother. | pmid:6927637 |
| Giovanetti E et al. | ICESp2905, the erm(TR)-tet(O) element of Streptococcus pyogenes, is formed by two independent integrative and conjugative elements. | 2012 | Antimicrob. Agents Chemother. | pmid:21986826 |
| Hu WS et al. | Outer membrane protein STM3031 (Ail/OmpX-like protein) plays a key role in the ceftriaxone resistance of Salmonella enterica serovar Typhimurium. | 2009 | Antimicrob. Agents Chemother. | pmid:19470505 |
| Severin JA et al. | Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population. | 2010 | Antimicrob. Agents Chemother. | pmid:20837756 |
| Singh KV et al. | In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci. | 2001 | Antimicrob. Agents Chemother. | pmid:11709359 |
| Chin NX and Neu HC | In vitro activity of MC-352, a new 16-membered macrolide. | 1992 | Antimicrob. Agents Chemother. | pmid:1416853 |
| English AR et al. | Evaluation of three 4"-deoxy-4"-sulfonamido-oleandomycin derivatives with erythromycin-like antibacterial potency. | 1984 | Antimicrob. Agents Chemother. | pmid:6703675 |